Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 28;13(10):776.
doi: 10.3390/biology13100776.

Phytochemistry and Evaluation of the Anti-Inflammatory Activity of the Hydroethanolic Extract of Virola elongata (Benth.) Warb. Stem Bark

Affiliations

Phytochemistry and Evaluation of the Anti-Inflammatory Activity of the Hydroethanolic Extract of Virola elongata (Benth.) Warb. Stem Bark

Bruna Fioravante Di Serio et al. Biology (Basel). .

Abstract

Background: Previous studies of the hydroethanolic extract of Virola elongata inner stem bark (HEVe) have demonstrated its antioxidant, gastroprotective, and antiulcer properties, but have not evaluated its anti-inflammatory potential.

Methods: HEVe was obtained by maceration and phytochemically analyzed. Its systemic anti-inflammatory activity was assessed by its effect on lipopolysaccharide (LPS)-induced peritonitis in mice. HEVe gel (HEgVe) was employed to evaluate topical anti-inflammatory activity by measuring the ear edema resulting from croton-oil-induced dermatitis in mice. A cell viability assay was conducted to determine the non-cytotoxic concentrations of the HEVe. RAW 264.7 cells were stimulated by LPS to determinate cytokine and nitric oxide production.

Results: A phytochemical analysis of the HEVe revealed the presence of phenolic acids, neolignans, flavonoids, and monomeric catechins. The oral treatment of acute peritonitis with HEVe reduced the total leukocytes, neutrophils, TNF-α, and IL-1β and elevated IL-10 levels. The application of the HEgVe reduced local edema. The HEVe on the RAW 264.7 cells exhibited no cytotoxicity, and the cells with HEVe displayed reduced TNF-α, IL-1β, and NO levels and increased IL-13 levels.

Conclusions: HEVe demonstrated systemic and topical multitarget anti-inflammatory activity, likely due to the combined effects of secondary metabolites. HEVe emerges as a promising herbal remedy for inflammation with minimal cytotoxicity, emphasizing its potential therapeutic significance.

Keywords: Virola elongata; cytotoxicity; extract; inflammation; leukocytes; phytochemistry.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
UHPLC-PDA-ESI-IT-MSn analysis of the hydroethanolic extract of Virola elongata inner stem bark (HEVe) was conducted, with detection using base peak ion (BPI). With a signal correspondence value of 1.86 × 105. The highlighted peaks represent some substances highlighted in Table 1.
Figure 2
Figure 2
Effect of oral administration of vehicle (Vehi 0.1 mL/10 g distilled water), hydroethanolic extract from the inner stem bark of Virola elongata (HEVe 5, 25, and 100 mg/kg), and dexamethasone (Dexa 0.5 mg/kg) on total cells, mononuclear (MN) cells, and polymorphonuclear (PMN) cells present in the intraperitoneal fluid of mice with LPS-induced peritonitis (250 ng/0.2 mL/well). Each column represents the mean ± SE of eight animals/group. One-way ANOVA, followed by the Student–Newman–Keuls test, ### p < 0.001 vs. naive, ** p < 0.01, and *** p < 0.001 vs. vehi.
Figure 3
Figure 3
Effect of oral administration of the vehicle (Vehi 0.1 mL/10 g of distilled water), hydroethanolic extract from the inner stem bark of Virola elongata (HEVe 5, 25, and 100 mg/kg), and dexamethasone (Dexa 0.5 mg/kg) on the concentrations of (A) tumor necrosis factor-alpha (TNF-α) and (B) interleukin-1 beta (IL-1β) in the peritoneal lavage of mice with peritonitis induced by intraperitoneal injection of LPS (250 ng/well/0.2 mL). The naive group received distilled water (0.1 mL/10 g p.o.) and 0.9% saline (0.2 mL/well i.p.). Each column represents the mean ± SE of eight animals/group. One-way ANOVA, followed by the Student–Newman–Keuls test, * p < 0.05 vs. Vehi, ** p < 0.01 vs. Vehi, *** p < 0.001 vs. Vehi, ### p < 0.001 vs. naive.
Figure 4
Figure 4
Effect of oral administration of the vehicle (Vehi 0.1 mL/10 g of distilled water), hydroethanolic extract from the inner stem bark of Virola elongata (HEVe 5, 25, and 100 mg/kg), and dexamethasone (Dexa 0.5 mg/kg), on the concentration of interleukin 10 (IL-10) in the peritoneal lavage of mice with peritonitis induced by intraperitoneal injection of LPS (250 ng/well/0.2 mL). The naive group received distilled water (0.1 mL/10 g p.o.) and 0.9% saline (0.2 mL/well i.p.). Each column represents the mean ± SE of eight animals/group. One-way ANOVA, followed by the Student–Newman–Keuls test, *** p < 0.001 vs. vehi.
Figure 5
Figure 5
Difference in weight of the ears of female mice after topical treatment with the vehicle (Vehi 20 µL of 2.5% croton oil in acetone:water (70:30)), hydroethanolic extract gel from the inner stem bark of Virola elongata (HEgVe 1, 3, and 9%), and dexamethasone (Dexa 0.05 mg/ear/20 µL). Each column represents the mean ± SE of eight animals/group. One-way ANOVA, followed by the Student–Newman–Keuls test, *** p < 0.001 vs. vehi.
Figure 6
Figure 6
Cytotoxicity assessment of the hydroethanolic extract from the bark of the stem of Virola elongata (HEVe 6.25–400 µg/mL) and doxorubicin (Doxo 0.0058–58 µg/mL in RAW 264.7 cells stimulated with lipopolysaccharide (LPS 1 µg/mL) for 24 (A), 48 (B), and 72 h (C). Inhibitory concentration at 50% (IC50 ± S.E.). Nonlinear regression analysis (curve fitting).
Figure 7
Figure 7
Effect of in vitro treatment with hydroethanolic extract from the bark of the stem of Virola elongata (HEVe 1, 5, and 20 µg/mL) and Nω-Nitro-L-arginine-methyl-ester (L-NAME 10 mM) on nitric oxide (NO) concentrations in RAW 264.7 cells stimulated with lipopolysaccharide (LPS 1 μg/mL) for 24 h. Cells in the basal group were treated with DMEM culture medium with 10% fetal bovine serum (FBS). One-way ANOVA, followed by the Student–Newman–Keuls test, ### p < 0.001 vs. Basal, *** p < 0.001 vs. LPS.
Figure 8
Figure 8
Effect of in vitro treatment with hydroethanolic extract from the inner stem bark of Virola elongata (HEVe 1, 5, and 20 µg/mL) and dexamethasone (Dexa 10 mM) on the concentration of the cytokines (A) TNF-α and (B) IL-1β in LPS (1 µg/mL)-stimulated RAW 264.7 cells. Cells in the basal group were treated only with DMEM culture medium with 10% fetal bovine serum (FBS). One-way ANOVA, followed by the Student–Newman–Keuls test, * p < 0.05 vs. LPS, ** p < 0.01 vs. LPS, *** p < 0.001 vs. LPS, ### p < 0.001 vs. Basal.
Figure 9
Figure 9
Effect of in vitro treatment with hydroethanolic extract from the inner stem bark of Virola elongata (HEVe 1, 5, and 20 µg/mL) and dexamethasone (Dexa 10 mM) on the concentration of the cytokine IL-13 in LPS (1 µg/mL)-stimulated RAW 264.7 cells. Cells in the basal group were treated only with DMEM culture medium with 10% fetal bovine serum (FBS). One-way ANOVA, followed by the Student–Newman–Keuls test, *** p < 0.001 vs. LPS, ### p < 0.001 vs. Basal.

Similar articles

References

    1. Pezone A., Olivieri F., Napoli M.V., Procopio A., Avvedimento E.V., Gabrielli A. Inflammation and DNA damage: Cause, effect or both. Nat. Rev. Rheumatol. 2023;19:200–211. doi: 10.1038/s41584-022-00905-1. - DOI - PubMed
    1. Zigterman B.G.R., Dubois L. Ontsteking en infectie: De cellulaire en biochemische processen [Inflammation and infection: Cellular and biochemical processes] Ned. Tijdschr. Tandheelkd. 2022;129:125–129. doi: 10.5177/ntvt.2022.03.21138. - DOI - PubMed
    1. Farber D.L., Netea M.G., Radbruch A., Rajewsky K., Zinkernagel R.M. Immunological Memory: Lessons from the past and a Look to the Future. Nat. Rev. Immunol. 2016;16:124–128. doi: 10.1038/nri.2016.13. - DOI - PubMed
    1. Chow C.W., Downey G.P. Basic biology and critical care medicine—Inflammation. In: Albert R.K., Slutsky A.S., Ranieri V.M., Torres A., Takala J., editors. Clinical Critical Care Medicine. 1st ed. Volume 1. Elsevier Inc.; Grand Rapids, MI, USA: 2006. pp. 1–12.
    1. Bengmark S. Acute and “Chronic” Phase Reaction-a Mother of Disease. Clin. Nutr. 2004;23:1256–1266. doi: 10.1016/j.clnu.2004.07.016. - DOI - PubMed

LinkOut - more resources